Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)
China
· Delayed Price · Currency is CNY 25.38
-0.68 (-2.61%)
Mar 9, 2026, 3:04 PM CST
Wuhan Hvsen Biotechnology Revenue
Wuhan Hvsen Biotechnology had revenue of 437.33M CNY in the quarter ending September 30, 2025, with 22.76% growth. This brings the company's revenue in the last twelve months to 1.67B, up 48.74% year-over-year. In the year 2024, Wuhan Hvsen Biotechnology had annual revenue of 1.20B with 17.71% growth.
Revenue (ttm)
1.67B
Revenue Growth
+48.74%
P/S Ratio
3.07
Revenue / Employee
1.62M
Employees
1,028
Market Cap
5.12B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ChemPartner PharmaTech | 1.07B |
| Hangzhou Biotest Biotech | 448.37M |
| Beijing Bohui Innovation Biotechnology Group | 834.38M |
| Jiangsu Bioperfectus Technologies | 340.38M |
| Assure Tech (Hangzhou) | 453.58M |
| PharmaResources (Shanghai) | 667.47M |
| Shanghai Obio Technology (Group) Corp. | 267.66M |
| Pulike Biological Engineering | 1.10B |